Joseph Wayne Singleton, a 45-year-old musician from Opelousas, Louisiana, underwent a routine physical at age 33 at his wife's urging, despite feeling healthy and having no symptoms [1]. During this checkup, his doctor decided to run a prostate-specific antigen (PSA) blood test, even though Singleton was considered too young for standard prostate cancer screening at the time [1]. The test revealed PSA levels that were 'through the roof,' leading to a biopsy and a subsequent diagnosis of prostate cancer, which doctors described as highly unusual for someone his age [1].
Singleton received treatment at UT MD Anderson Cancer Center in Houston, Texas, where he underwent a prostatectomy. He attributed his 'miraculous' recovery to his relatively young age, noting that he was able to resume performing with his band just weeks after surgery [1]. Singleton reflected on the experience as life-changing and now uses his platform to advocate for earlier prostate cancer screening, especially for younger men who may not show symptoms [1].
He emphasized that early testing was crucial in his case, stating, 'This could have turned out so much worse had I not gotten tested early,' and expressed a desire to help others avoid similar or worse outcomes [1]. Singleton has received outreach from people across the country who have been inspired by his story [1].
However, current screening guidelines do not recommend routine prostate cancer screening for younger men without symptoms. Robert Smith, Ph.D., senior vice president of cancer screening at the American Cancer Society, confirmed that screening procedures vary depending on the patient, and most organizations agree that clinicians should discuss prostate cancer screening with their patients [1].
CONCLUSION
Joseph Singleton's unexpected prostate cancer diagnosis at a young age highlights the potential benefits of early screening, though current medical guidelines do not support routine testing for asymptomatic younger men. His recovery and advocacy efforts may prompt further discussion about screening practices, but no changes to official recommendations have been reported.